{"id":"W3114561183","doi":"10.1016/j.ahj.2020.12.008","title":"Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University of British Columbia","funders":"Janssen Research and Development; Relypsa; NxStage; Janssen Scientific Affairs; Janssen Pharmaceuticals; Gilead Sciences; Novo Nordisk; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Canagliflozin; Medicine; Heart failure; Type 2 diabetes; Kidney disease; Diabetes mellitus; Nephropathy; Internal medicine; Placebo; Clinical trial; Cardiology; Intensive care medicine; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003076759,0.001155649,0.002210894,0.0003613414,0.000521267,0.001515284,0.0007134342,0.001553256,0.002836299],"category_scores_gemma":[0.005185884,0.0004629185,0.002624517,0.0004998792,0.001136947,0.001383395,0.0007793864,0.002899539,0.0004048729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007643831,"about_ca_system_score_gemma":0.000745611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003371796,"about_ca_topic_score_gemma":0.005761677,"domain_scores_codex":[0.9990312,0.0004630901,0.0000620709,0.0001711813,0.0001154517,0.0001571394],"domain_scores_gemma":[0.9978921,0.0007735797,0.0005209316,0.0002638222,0.0001156646,0.0004339732],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9088448,0.005880794,0.04619672,0.0007612556,0.007926325,0.00009827544,0.000173363,0.000607948,0.0009213095,0.0003613087,0.003738367,0.02448944],"study_design_scores_gemma":[0.683909,0.04349854,0.2480285,0.0002681485,0.01642837,0.000169666,0.0003649854,0.002131243,0.0005867575,0.001447732,0.003023173,0.0001438841],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992476,0.003420209,0.0001122086,0.0007560179,0.0002794913,0.0001529206,0.0007195871,0.00003380754,0.002049626],"genre_scores_gemma":[0.9957961,0.0008204625,0.0002265424,0.0008490264,0.0003377856,0.0001451159,0.001076729,0.000006548285,0.0007417183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003371796,"threshold_uncertainty_score":0.01627165,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02275117013111997,"score_gpt":0.2595466790822277,"score_spread":0.2367955089511078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}